BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03833427-completion@plaintrial.com
DTSTAMP:20261029T034758Z
DTSTART;VALUE=DATE:20220628
SUMMARY:Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (M
 K-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001
 ) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03833427
URL:https://plaintrial.com/trial/NCT03833427
END:VEVENT
END:VCALENDAR